Display options
Cite
Everts B, Pearce EJ. Metabolic control of dendritic cell activation and function: recent advances and clinical implications. Front Immunol. 2014;5:203doi: 10.3389/fimmu.2014.00203.
Everts, B., & Pearce, E. J. (2014). Metabolic control of dendritic cell activation and function: recent advances and clinical implications. Frontiers in immunology, 5203. https://doi.org/10.3389/fimmu.2014.00203
Everts, Bart, and Pearce, Edward J. "Metabolic control of dendritic cell activation and function: recent advances and clinical implications." Frontiers in immunology vol. 5 (2014): 203. doi: https://doi.org/10.3389/fimmu.2014.00203
Everts B, Pearce EJ. Metabolic control of dendritic cell activation and function: recent advances and clinical implications. Front Immunol. 2014 May 08;5:203. doi: 10.3389/fimmu.2014.00203. eCollection 2014. PMID: 24847328; PMCID: PMC4021118.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2014 May 08;5:203. doi: 10.3389/fimmu.2014.00203. eCollection 2014.

Metabolic control of dendritic cell activation and function: recent advances and clinical implications.

Frontiers in immunology

Bart Everts, Edward J Pearce

Affiliations

  1. Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, MO , USA ; Department of Parasitology, Leiden University Medical Center , Leiden , Netherlands.
  2. Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, MO , USA.

PMID: 24847328 PMCID: PMC4021118 DOI: 10.3389/fimmu.2014.00203

Abstract

Dendritic cells (DCs) are key regulators of both immunity and tolerance by controlling activation and polarization of effector T helper cell and regulatory T cell responses. Therefore, there is a major focus on developing approaches to manipulate DC function for immunotherapy. It is well known that changes in cellular activation are coupled to profound changes in cellular metabolism. Over the past decade there is a growing appreciation that these metabolic changes also underlie the capacity of immune cells to perform particular functions. This has led to the concept that the manipulation of cellular metabolism can be used to shape innate and adaptive immune responses. While most of our understanding in this area has been gained from studies with T cells and macrophages, evidence is emerging that the activation and function of DCs are also dictated by the type of metabolism these cells commit to. We here discuss these new insights and explore whether targeting of metabolic pathways in DCs could hold promise as a novel approach to manipulate the functional properties of DCs for clinical purposes.

Keywords: TLR signaling; glycolysis; immunogenic dendritic cells; immunotherapy; metabolism; mitochondria; oxidative phosphorylation; tolerogenic dendritic cells

References

  1. J Proteome Res. 2012 Feb 3;11(2):941-71 - PubMed
  2. Immunol Rev. 2012 Sep;249(1):43-58 - PubMed
  3. Cell Metab. 2006 Jul;4(1):13-24 - PubMed
  4. J Invest Dermatol. 2009 Oct;129(10):2451-62 - PubMed
  5. Blood. 2010 Jun 10;115(23):4742-9 - PubMed
  6. Immunology. 2010 Apr;129(4):525-35 - PubMed
  7. Cell. 2012 Apr 13;149(2):274-93 - PubMed
  8. Clin Exp Immunol. 2013 May;172(2):148-57 - PubMed
  9. Cytotherapy. 2013 Jun;15(6):740-9 - PubMed
  10. Cell. 2006 Dec 15;127(6):1109-22 - PubMed
  11. Int Rev Immunol. 2010 Dec;29(6):574-607 - PubMed
  12. Genes Dev. 2013 Oct 1;27(19):2072-85 - PubMed
  13. Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9977-82 - PubMed
  14. PLoS One. 2010 Jun 07;5(6):e0010983 - PubMed
  15. Cell Signal. 2013 Sep;25(9):1895-903 - PubMed
  16. Nature. 2009 Jul 2;460(7251):108-12 - PubMed
  17. Ann N Y Acad Sci. 2013 Jul;1290:74-82 - PubMed
  18. J Neuroinflammation. 2011 Jan 05;8(1):1 - PubMed
  19. J Immunol. 2010 Oct 1;185(7):3919-31 - PubMed
  20. Blood. 2012 Aug 16;120(7):1422-31 - PubMed
  21. Cancer Res. 2010 Jan 1;70(1):89-98 - PubMed
  22. Nature. 2013 Apr 11;496(7444):238-42 - PubMed
  23. Adv Immunol. 2010;108:111-65 - PubMed
  24. Clin Exp Allergy. 2007 Nov;37(11):1709-19 - PubMed
  25. Curr Opin Cell Biol. 2006 Dec;18(6):598-608 - PubMed
  26. Biol Chem. 2013 Apr;394(4):495-505 - PubMed
  27. Cancer Treat Rev. 2013 Dec;39(8):891-907 - PubMed
  28. Nat Med. 2010 Aug;16(8):880-6 - PubMed
  29. Immunity. 2010 Nov 24;33(5):699-712 - PubMed
  30. Immunity. 2013 Apr 18;38(4):633-43 - PubMed
  31. Biochim Biophys Acta. 2011 Apr;1813(4):634-44 - PubMed
  32. Int Immunopharmacol. 2013 May;16(1):85-92 - PubMed
  33. Nat Immunol. 2013 May;14(5):489-99 - PubMed
  34. Proteomics. 2009 Jul;9(14):3752-64 - PubMed
  35. Trends Immunol. 2012 Apr;33(4):168-73 - PubMed
  36. Science. 2009 May 22;324(5930):1029-33 - PubMed
  37. Cell Metab. 2011 May 4;13(5):540-9 - PubMed
  38. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):E4894-903 - PubMed
  39. J Biol Chem. 2012 Mar 23;287(13):10556-10564 - PubMed
  40. Drug Test Anal. 2012 Nov;4(11):830-45 - PubMed
  41. Immunol Rev. 2009 Jan;227(1):234-47 - PubMed
  42. Int J Oncol. 2013 Jul;43(1):280-8 - PubMed
  43. Handb Exp Pharmacol. 2009;(188):215-32 - PubMed
  44. J Immunol. 2007 Feb 15;178(4):2122-31 - PubMed
  45. Semin Immunol. 2012 Dec;24(6):429-35 - PubMed
  46. Curr Opin Lipidol. 2012 Jun;23(3):226-234 - PubMed
  47. Mol Cells. 2013 Oct;36(4):279-87 - PubMed
  48. Diabetes Care. 2011 Sep;34(9):2026-32 - PubMed
  49. Nat Rev Mol Cell Biol. 2012 Mar 07;13(4):225-238 - PubMed
  50. J Leukoc Biol. 2013 Dec;94(6):1113-21 - PubMed
  51. Biol Pharm Bull. 2009 Jun;32(6):988-92 - PubMed
  52. ScientificWorldJournal. 2011;11:2509-29 - PubMed
  53. J Immunol. 2008 Apr 1;180(7):4697-705 - PubMed
  54. Immunol Rev. 2010 Mar;234(1):90-104 - PubMed
  55. Nat Immunol. 2014 Apr;15(4):323-32 - PubMed
  56. Oncoimmunology. 2012 Oct 1;1(7):1111-1134 - PubMed
  57. Cell Death Dis. 2013 Mar 07;4:e532 - PubMed
  58. Nature. 2009 Jul 2;460(7251):103-7 - PubMed
  59. Cell. 2003 Mar 7;112(5):645-57 - PubMed
  60. Nat Immunol. 2010 Aug;11(8):647-55 - PubMed
  61. Hum Vaccin Immunother. 2014;10(2):321-32 - PubMed
  62. J Biol Chem. 2007 Jul 13;282(28):20534-43 - PubMed
  63. J Cancer Res Ther. 2009 Sep;5 Suppl 1:S21-6 - PubMed
  64. Nature. 2007 Jun 28;447(7148):1116-20 - PubMed
  65. Am J Respir Cell Mol Biol. 2010 Sep;43(3):276-85 - PubMed
  66. Transplant Res. 2012 Sep 28;1(1):16 - PubMed
  67. J Control Release. 2012 May 30;160(1):88-95 - PubMed
  68. PLoS Biol. 2014 Jan;12(1):e1001759 - PubMed
  69. Int Immunopharmacol. 2004 Feb;4(2):245-53 - PubMed
  70. Nature. 2013 Jan 17;493(7432):346-55 - PubMed
  71. Nat Rev Immunol. 2005 Nov;5(11):844-52 - PubMed
  72. Immunol Rev. 2012 Sep;249(1):27-42 - PubMed
  73. N Engl J Med. 2010 Jul 29;363(5):411-22 - PubMed
  74. Arch Pharm Res. 2011 Oct;34(10):1583-5 - PubMed
  75. Blood. 2007 Nov 1;110(9):3271-80 - PubMed
  76. Gastroenterology. 2012 Oct;143(4):1061-72 - PubMed
  77. Blood. 2008 Aug 1;112(3):635-43 - PubMed
  78. J Immunol. 2012 Sep 1;189(5):2151-8 - PubMed
  79. FEBS Lett. 1994 May 23;345(1):50-4 - PubMed
  80. J Immunol. 2005 Jul 1;175(1):566-74 - PubMed
  81. J Immunol. 2014 Mar 15;192(6):2920-31 - PubMed
  82. J Pharmacol Exp Ther. 2006 Jul;318(1):59-67 - PubMed

Publication Types

Grant support